Wells Fargo & Company (NYSE:WFC)’s Wealth, Brokerage and Retirement (WBR) division today announced the launch of Wells Fargo Investment Institute (WFII). WFII brings together the investment research, strategy, manager research and publications teams from WBR’s four lines of business to create a single group with a goal of providing world-class advice to the company’s financial and wealth advisors and clients. Wells Fargo & Company (NYSE:WFC) belongs to Financial sector. Its net profit margin is 46.20% and weekly performance is 0.41%. On last trading day company shares ended up $54.50. Wells Fargo & Company (NYSE:WFC) distance from 50-day simple moving average (SMA50) is 4.84%.

On Nov 30, U.S. drugmaker AbbVie Inc. (NYSE:ABBV) has added two HIV medicines for children to a shared patent pool in an initiative that should speed the development of cheap new pediatric formulations for use in poor countries. AbbVie Inc. (NYSE:ABBV) shares increased 1.56% in last trading session and ended the day at $69.57. ABBV Gross Margin is 76.90% and its return on assets is 12.90%. AbbVie Inc. (NYSE:ABBV) quarterly performance is 25.28%.

Sigma-Aldrich® Corporation (NASDAQ: SIAL), announced that Sigma® Life Science, its innovative biological products and services business, has entered into a non-exclusive agreement for the use of CRISPR/Cas technology covered under patents held by the Broad Institute of MIT and Harvard. Under the agreement, Sigma-Aldrich is able to make, use and distribute the advanced gene editing tools for numerous research applications, including the generation of modified plant and animal models, custom cell line creation and for CRISPR/Cas arrayed and pooled genetic screening. On 04 December, Sigma-Aldrich Corporation (NASDAQ:SIAL) shares increased 0.23% and was closed at $136.54. SIAL EPS growth in last 5 year was 8.90%. Sigma-Aldrich Corporation (NASDAQ:SIAL) year to date (YTD) performance is 46.50%.

French drug maker Sanofi SA (ADR) (NYSE:SNY) announced that Merial, its animal health company, will acquire the Merck manufacturing facility in Barceloneta, Puerto Rico. The proposed transaction requires approval from the United States Federal Trade Commission. Sanofi SA (ADR) (NYSE:SNY) belongs to Healthcare sector. Its net profit margin is 12.40% and weekly performance is -2.79%. On last trading day company shares ended up $46.75. Sanofi SA (ADR) (NYSE:SNY) distance from 50-day simple moving average (SMA50) is -6.94%.

Sprint Corporation (NYSE:S) is leaving no stone unturned to intensify the wireless pricing war in the U.S. The third largest wireless communication company in the country has claimed that it will reduce the phone bills of AT&T (T) and Verizon Communications (VZ) customers by 50% if they switch to Sprint. Sprint Corporation (NYSE:S) shares advanced 3.62% in last trading session and ended the day at $4.86. S Gross Margin is 44.50% and its return on assets is -2.30%. Sprint Corporation (NYSE:S) quarterly performance is -17.49%.